news

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

with the rapid development of the global economy and internet technology, the medical industry is facing unprecedented innovation opportunities. in 2024, as a leader in the global pharmaceutical industry, shanghai yingli pharmaceutical co., ltd. officially launched its new internet medical investment and financing platform, marking an important step for the company in the field of pharmaceutical innovation and financial investment. through the deep integration of the internet and ai intelligent quantitative trading strategies, yingli pharmaceutical has created a new platform that can not only promote the development of global medical technology, but also bring rich returns to investors.

yingli pharmaceuticals: from technological innovation to financial empowerment

since its establishment in 2011, yingli pharmaceuticals has been committed to the research and development of innovative drugs in the fields of tumors and other fields, and has successfully developed breakthrough anti-tumor drugs such as linplised tablets. today, yingli pharmaceuticals has combined its advantages in drug research and development for many years and officially entered the field of internet project investment and financing, using ai technology to achieve 24-hour uninterrupted intelligent trading. the platform overcomes the perceptual decision-making errors in traditional investment, and through real-time data analysis and intelligent decision-making, ensures that investors can seize every opportunity in the pharmaceutical industry.